123 related articles for article (PubMed ID: 38040060)
21. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
22. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
[TBL] [Abstract][Full Text] [Related]
23. Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancer.
Trifiletti DM; Grover S; Libby B; Showalter TN
Brachytherapy; 2017; 16(3):547-551. PubMed ID: 28336252
[TBL] [Abstract][Full Text] [Related]
24. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
25. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
26. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
27. High versus low-dose rate brachytherapy for cervical cancer.
Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
[TBL] [Abstract][Full Text] [Related]
28. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
[TBL] [Abstract][Full Text] [Related]
30. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
31. PSA: Declining utilization of prostate brachytherapy.
Andring L; Yoder A; Pezzi T; Tang C; Kumar R; Mahmood U; Walker GV
Brachytherapy; 2022; 21(1):6-11. PubMed ID: 34420862
[TBL] [Abstract][Full Text] [Related]
32. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
33. Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea.
Kim YA; Yang MS; Park M; Choi MG; Kim SY; Kim YJ
J Gynecol Oncol; 2021 Nov; 32(6):e85. PubMed ID: 34431256
[TBL] [Abstract][Full Text] [Related]
34. High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
Yamashita H; Niibe Y; Toita T; Kazumoto T; Nishimura T; Kodaira T; Eto H; Kinoshita R; Tsujino K; Onishi H; Takemoto M; Hayakawa K
Jpn J Clin Oncol; 2013 May; 43(5):547-52. PubMed ID: 23475536
[TBL] [Abstract][Full Text] [Related]
35. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
[TBL] [Abstract][Full Text] [Related]
36. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.
Modh A; Ghanem AI; Burmeister C; Rasool N; Elshaikh MA
Brachytherapy; 2016; 15(5):554-61. PubMed ID: 27475480
[TBL] [Abstract][Full Text] [Related]
37. Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer.
Murofushi K; Yoshioka Y; Sumi M; Ishikawa H; Oguchi M; Sakurai H
Int J Gynecol Cancer; 2020 Apr; 30(4):473-479. PubMed ID: 32165406
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
39. Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States.
Rajagopalan MS; Xu KM; Lin J; Hansen K; Sukumvanich P; Krivak TC; Kelley JL; Beriwal S
Pract Radiat Oncol; 2015; 5(1):56-61. PubMed ID: 25413431
[TBL] [Abstract][Full Text] [Related]
40. Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival.
Moelle U; Mathewos A; Aynalem A; Wondemagegnehu T; Yonas B; Begoihn M; Addissie A; Unverzagt S; Jemal A; Thomssen C; Vordermark D; Kantelhardt EJ
Oncologist; 2018 Sep; 23(9):1024-1032. PubMed ID: 29567823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
